5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits
- 20 July 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 238 (2-3) , 291-296
- https://doi.org/10.1016/0014-2999(93)90859-g
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Combined administration of a non-neurotoxic 3,4-methylenedioxymethamphetamine analogue with amphetamine produces serotonin neurotoxicity in ratsNeuropharmacology, 1991
- Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA)Journal of Medicinal Chemistry, 1991
- Neurotoxicity of MDMA: Neurochemical EffectsAnnals of the New York Academy of Sciences, 1990
- Effect of 3,4‐Methylenedioxymethamphetamine on 3,4‐Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus AccumbensJournal of Neurochemistry, 1990
- Nonneurotoxic tetralin and indan analogs of 3,4-(methylenedioxy)amphetamine (MDA)Journal of Medicinal Chemistry, 1990
- Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by microdialysisLife Sciences, 1990
- Neurotoxic effects of the alpha-ethyl homologue of MDMA following subacute administrationPharmacology Biochemistry and Behavior, 1989
- Evidence for dual serotonergic projections to neocortex: Axons from the dorsal and median raphe nuclei are differentially vulnerable to the neurotoxin p-chloroamphetamine (PCA)Experimental Neurology, 1988
- Central serotonin receptors as targets for drug researchJournal of Medicinal Chemistry, 1987
- Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic classJournal of Medicinal Chemistry, 1986